SEQUELLA Trademark

Trademark Overview

On Wednesday, September 9, 1998, a trademark application was filed for SEQUELLA with the United States Patent and Trademark Office. The USPTO has given the SEQUELLA trademark a serial number of 75550280. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, March 22, 2022. This trademark is owned by Sequella, Inc.. The SEQUELLA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and medical research services; medical laboratories; providing scientific and medical information, consultation, product development, and laboratory research in the field of infectious diseases
sequella

General Information

Serial Number75550280
Word MarkSEQUELLA
Filing DateWednesday, September 9, 1998
Status800 - REGISTERED AND RENEWED
Status DateTuesday, March 22, 2022
Registration Number2451448
Registration DateTuesday, May 15, 2001
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 18, 1999

Trademark Statements

Goods and ServicesScientific and medical research services; medical laboratories; providing scientific and medical information, consultation, product development, and laboratory research in the field of infectious diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 22, 1998
Primary Code042
First Use Anywhere DateSunday, January 19, 1997
First Use In Commerce DateSunday, January 19, 1997

Trademark Owner History

Party NameSequella, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameSequella, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 208491067
Party NameSequella, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 208491067

Trademark Events

Event DateEvent Description
Tuesday, March 22, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, March 22, 2022REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, March 22, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 22, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 15, 2021TEAS SECTION 8 & 9 RECEIVED
Friday, May 15, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, November 8, 2010REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, November 8, 2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, November 5, 2010TEAS SECTION 8 & 9 RECEIVED
Tuesday, June 15, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 15, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 29, 2007REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 22, 2007ASSIGNED TO PARALEGAL
Monday, April 23, 2007REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, April 23, 2007TEAS SECTION 8 & 15 RECEIVED
Thursday, December 21, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 21, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 6, 2006CASE FILE IN TICRS
Tuesday, May 15, 2001REGISTERED-PRINCIPAL REGISTER
Friday, February 23, 2001ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 20, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 13, 2000NON-FINAL ACTION MAILED
Monday, September 11, 2000STATEMENT OF USE PROCESSING COMPLETE
Monday, July 17, 2000USE AMENDMENT FILED
Tuesday, April 11, 2000SOU EXTENSION 1 GRANTED
Thursday, February 10, 2000SOU EXTENSION 1 FILED
Tuesday, August 10, 1999NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 18, 1999PUBLISHED FOR OPPOSITION
Friday, April 16, 1999NOTICE OF PUBLICATION
Tuesday, February 9, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 2, 1999EXAMINER'S AMENDMENT MAILED
Wednesday, January 20, 1999ASSIGNED TO EXAMINER

Related Keywords

sequella medical scientific research field laboratory diseases development infectious information services